SICCARDI, ANTONIO
SICCARDI, ANTONIO
DIPARTIMENTO DI BIOLOGIA E GENETICA PER LE SCIENZE MEDICHE (attivo dal 01/11/1983 al 26/04/2012)
A Combined NMR-Computational Study of the Interaction between Influenza Virus Hemagglutinin and Sialic Derivatives from Human and Avian Receptors on the Surface of Transfected Cells
2018 F. Vasile, M. Panigada, A. Siccardi, D. Potenza, G. Tiana
AllergoOncology : the role of IgE-mediated allergy in cancer
2008 E. Jensen-Jarolim, G. Achatz, M.C. Turner, S. Karagiannis, F. Legrand, M. Capron, M.L. Penichet, J.A. Rodríguez, A. Siccardi, L. Vangelista, A.B. Riemer, H. Gould
An antitumor cellular vaccine based on a mini-membrane IgE
2012 E.A. Nigro, E. Soprana, A.T. Brini, A. Ambrosi, V.A. Yenagi, D. Dombrowicz, A.G. Siccardi, L. Vangelista
Anti HLA antibodies associated with resistance to HIV infection
1995 A.M. Beretta, C. De Santis, A. Cosma, L. Lopalco, S. Weiss, M. Clerici, A. Lazzarin, A.G. Siccardi
Anti-human tumor antibodies induced in mice and rabbits by" internal image" anti-idiotypic monoclonal immunoglobulins
1987 G Viale, F Grassi, M Pelagi, R Alzani, S Menard, S Miotti, R Buffa, A Gini, AG Siccardi
Antitumor IgE adjuvanticity : key role of Fc epsilon RI
2009 E.A. Nigro, A.T. Brini, E. Soprana, A. Ambrosi, D. Dombrowicz, A. Siccardi, L. Vangelista
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro
2000 L. Lopalco, C. Barassi, C. Pastori, R. Longhi, S.E. Burastero, G. Tambussi, F. Mazzotta, A. Lazzarin, M. Clerici, A.G. Siccardi
Direct interaction of complement factor H with the C1 domain of HIV type 1 glycoprotein 120
1995 C. Pintèr, A.G. Siccardi, R. Longhi, A. Clivio
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)
1996 H. Stoiber, C. Pintèr, A.G. Siccardi, A. Clivio, M.P. Dierich
Hedgehogs, humans and high-school science : the benefits of involving high-school students in university research
2008 G. Pavesi, A. Siccardi, G. Viale, C. Grazioli, T. Calciolari, M.L.G. Tenchini, P. Plevani
HIV env glycoprotein shares a cross‐reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation
1987 Beretta, F Grassi, M Pelagi, A Clivio, C Parravicini, G Giovinazzo, F Andronico, L Lopalco, P Verani, S Butto, F Titti, GB Rossi, G Viale, E Ginelli, AG Siccardi
HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology.
1995 C. Pintèr, A. G. Siccardi, L. Lopalco, R. Longhi, A. Clivio
HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket
2000 C. Pastori, C. Barassi, S. Piconi, R. Longhi, M.L. Villa, A.G. Siccardi, M. Clerici, L. Lopalco
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection
1996 A. Beretta, L. Furci, S. Burastero, A. Cosma, M.E. Dinelli, L. Lopalco, C. Desantis, G. Tambussi, E. Carrow, S. Sabbatani, M. Clerici, A. Lazzarin, A.G. Siccardi
HLA-C increases HIV-1 infectivity and is associated with gp120
2008 A. Matucci, P. Rossolillo, M. Baroni, A. Siccardi, A. Beretta, D. Zipeto
HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes
2010 M. Baroni, A. Matucci, G. Scarlatti, E. Soprana, P. Rossolillo, L. Lopalco, D. Zipeto, A. Siccardi, C. De Santis
Idiotypic replica of an anti-human tumor-associated antigen monoclonal antibody. Analysis of monoclonal Ab1 and Ab3 fine specificity
1989 G Viale, G Flamini, F Grassi, R Buffa, PG Natali, M Pelagi, F Leoni, S Menard, AG Siccardi
IgE present powerful activity in anti-tumor vaccination
2007 E.A. Nigro, A.T. Brini, G. Achatz, L. Vangelista, A.G. Siccardi
IMMUNOSURVEILLANCE OF TUMORS: IGE AS A NEW PLAYER
2017 E.A. Nigro, L.M. Ferreira, G. Achatz-Straussberger, A. Ambrosi, F. Sanvito, A.G. Siccardi, L. Vangelista, A.T. Brini
Improved thymopoietic potential in aviremic HIV-infected individuals treated with HAART by intermittent IL-2 administration
2003 S. Porcellini, G. Vallanti, S. Nozza, G. Poli, A. Lazzarin, G. Tambussi, A.G. Siccardi, F. Grassi